Dr Reddys Laboratories (RDY) Other financing activities (2018 - 2021)
Dr Reddys Laboratories (RDY) posted Other financing activities of -$13.8 million for Q1 2021, down 102.17% on a QoQ basis from -$6.8 million in Q2 2019.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Other financing activities (2018 - 2021) Analysis & Trends
Dr Reddys Laboratories has reported Other financing activities for 3 years, with the latest figure at -$13.8 million in Q1 2021.
- On a quarterly basis, Other financing activities changed N/A year-over-year to -$13.8 million in Q1 2021; TTM through Mar 2021 was -$13.8 million, a 102.17% decrease from a year earlier, with the FY2025 full-year figure at -$16.0 million, changed N/A from the prior year.
- Other financing activities was -$13.8 million for Q1 2021 at Dr Reddys Laboratories, down from -$6.8 million in the prior quarter.
- The five-year high for Other financing activities was -$552845.1 in Q1 2019, with the low at -$13.8 million in Q1 2021.
- Average Other financing activities over 3 years is -$6.8 million, with a median of -$6.4 million recorded in 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.55 Bn | 38.89 Bn | 2.15 Bn |
| 2 | Viatris | 19.15 Bn | 18.26 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.87 Bn | 9.70 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.32 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 401.76 Mn | 360.51 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | -13.76 Mn |
| Jun 30, 2019 | -6.80 Mn |
| Mar 31, 2019 | -552,845.15 |
| Dec 31, 2018 | -5.98 Mn |